Evidence map›Paper›PMID 38470807›Full record

ArticleNanomaterials (Basel, Switzerland)2024

Regioselectively Carboxylated Cellulose Nanofibril Models from Dissolving Pulp: C6 via TEMPO Oxidation and C2,C3 via Periodate-Chlorite Oxidation.

Mengzhe Guo, James D Ede, Christie M Sayes, Jo Anne Shatkin, Nicole Stark, You-Lo Hsieh

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Mengzhe GuoChemical Engineering, University of California at Davis, Davis, CA 95616, USA.
James D EdeVireo Advisors, LLC, P.O. Box 51368, Boston, MA 02130, USA.ORCID 0000-0002-9470-9859
Christie M SayesEnvironmental Science, Baylor University, Waco, TX 76798, USA.
Jo Anne ShatkinVireo Advisors, LLC, P.O. Box 51368, Boston, MA 02130, USA.ORCID 0000-0001-9015-8642
Nicole StarkUSDA Forest Service, Forest Products Laboratory, Madison, WI 53726, USA.
You-Lo HsiehBiological and Agricultural Engineering, Chemical Engineering, University of California at Davis, Davis, CA 95616, USA.ORCID 0000-0003-4795-260X
Healthcentric Advisors · USUniversity of California, Davis · USBaylor University · USForest Products Laboratory · US

Funding

U.S. Endowment for Forestry and Communities none
6 · The paper itself

Abstract

Regioselective C6 and C2,C3 carboxylated cellulose nanofibrils (CNFs) have been robustly generated from dissolving pulp, a readily available source of unmodified cellulose, via stoichiometrically optimized 2,2,6,6-tetramethylpyperidine-1-oxyl (TEMPO)-mediated and sequential sodium periodate-sodium chlorite (PC) oxidation coupled with high-speed blending. Both regioselectively optimized carboxylated CNF series possess the widest ranges of comparable charges (0.72-1.48 mmol/g for T-CNFs vs. 0.72-1.10 mmol/g for PC-CNFs), but similar ranges of thickness (1.3-2.4 nm for T-CNF, 1.8-2.7 nm PC-CNF), widths (4.6-6.6 nm T-CNF, 5.5-5.9 nm PC-CNF), and lengths (254-481 nm T-CNF, 247-442 nm PC-CNF). TEMPO-mediated oxidation is milder and one-pot, thus more time and process efficient, whereas the sequential periodate-chlorite oxidation produces C2,C3 dialdehyde intermediates that are amenable to further chemical functionalization or post-reactions. These two well-characterized regioselectively carboxylated CNF series represent coherent cellulose nanomaterial models from a single woody source and have served as references for their safety study toward the development of a safer-by-design substance evaluation tool.

Indexed as

C2,C3 regioselectivecellulose nanofibrildissolving pulpperiodate–chlorite oxidationTEMPO

Identifiers

PMID38470807
PMCPMC10934283
OpenAlexW4392547176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.